Group One Trading, L.P. Axsome Therapeutics, Inc. Transaction History

Group One Trading, L.P.

  • $2.68 Billion
  • Q2 2025

A detailed history of Group One Trading, L.P. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 36,528 shares of AXSM stock, worth $4.34 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
36,528
Previous 25,523 43.12%
Holding current value
$4.34 Million
Previous $2.98 Million 28.13%
% of portfolio
0.14%
Previous 0.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$95.65 - $116.49 $1.05 Million - $1.28 Million
11,005 Added 43.12%
36,528 $3.81 Million
Q1 2025

May 14, 2025
SELL
$80.05 - $137.75 $1.46 Million - $2.52 Million
-18,297 Reduced 41.75%
25,523 $2.98 Million
Q4 2024

Feb 14, 2025
SELL
$83.08 - $100.49 $525,148 - $635,197
-6,321 Reduced 12.61%
43,820 $3.71 Million
Q3 2024

Nov 14, 2024
BUY
$78.93 - $95.84 $3.96 Million - $4.81 Million
50,141 New
50,141 $4.51 Million
Q1 2024

May 10, 2024
BUY
$69.39 - $97.64 $1.43 Million - $2.01 Million
20,543 Added 137.71%
35,461 $2.83 Million
Q4 2023

Feb 14, 2024
SELL
$57.42 - $83.61 $312,422 - $454,922
-5,441 Reduced 26.73%
14,918 $1.19 Million
Q3 2023

Nov 09, 2023
SELL
$69.25 - $82.21 $679,342 - $806,480
-9,810 Reduced 32.52%
20,359 $1.42 Million
Q2 2023

Aug 09, 2023
BUY
$58.41 - $90.35 $1.37 Million - $2.12 Million
23,473 Added 350.55%
30,169 $2.17 Million
Q1 2023

May 12, 2023
SELL
$58.39 - $75.0 $7 Million - $8.99 Million
-119,859 Reduced 94.71%
6,696 $413,000
Q4 2022

Feb 09, 2023
SELL
$39.94 - $79.72 $289,285 - $577,411
-7,243 Reduced 5.41%
126,555 $9.76 Million
Q3 2022

Nov 09, 2022
SELL
$36.06 - $69.85 $4.11 Million - $7.96 Million
-113,910 Reduced 45.99%
133,798 $5.97 Million
Q2 2022

Aug 11, 2022
SELL
$21.74 - $46.75 $1.22 Million - $2.62 Million
-56,065 Reduced 18.46%
247,708 $9.49 Million
Q1 2022

May 12, 2022
SELL
$23.7 - $41.39 $2.6 Million - $4.54 Million
-109,736 Reduced 26.54%
303,773 $12.6 Million
Q4 2021

Feb 11, 2022
BUY
$30.7 - $43.36 $6.61 Million - $9.33 Million
215,264 Added 108.58%
413,509 $15.6 Million
Q3 2021

Nov 12, 2021
BUY
$19.91 - $68.26 $2.57 Million - $8.81 Million
129,014 Added 186.35%
198,245 $6.53 Million
Q2 2021

Aug 10, 2021
BUY
$50.63 - $73.5 $1.09 Million - $1.58 Million
21,471 Added 44.96%
69,231 $4.67 Million
Q1 2021

May 12, 2021
BUY
$55.91 - $81.44 $217,713 - $317,127
3,894 Added 8.88%
47,760 $2.7 Million
Q4 2020

Feb 10, 2021
SELL
$66.31 - $86.52 $128,376 - $167,502
-1,936 Reduced 4.23%
43,866 $3.57 Million
Q3 2020

Nov 12, 2020
SELL
$68.34 - $85.84 $406,417 - $510,490
-5,947 Reduced 11.49%
45,802 $3.26 Million
Q2 2020

Aug 13, 2020
BUY
$49.87 - $98.69 $2.58 Million - $5.11 Million
51,749 New
51,749 $4.26 Million
Q1 2020

May 13, 2020
SELL
$41.2 - $101.31 $2.08 Million - $5.11 Million
-50,431 Closed
0 $0
Q4 2019

Feb 10, 2020
SELL
$16.71 - $106.24 $671,842 - $4.27 Million
-40,206 Reduced 44.36%
50,431 $5.21 Million
Q3 2019

Nov 12, 2019
BUY
$20.24 - $29.16 $614,466 - $885,268
30,359 Added 50.36%
90,637 $1.83 Million
Q2 2019

Aug 09, 2019
BUY
$13.46 - $25.75 $72,064 - $137,865
5,354 Added 9.75%
60,278 $1.55 Million
Q1 2019

May 13, 2019
BUY
$2.63 - $16.34 $117,902 - $732,522
44,830 Added 444.13%
54,924 $782,000
Q4 2018

Feb 06, 2019
SELL
$2.0 - $4.15 $6,202 - $12,869
-3,101 Reduced 23.5%
10,094 $28,000
Q3 2018

Nov 08, 2018
BUY
$2.3 - $3.55 $7,957 - $12,283
3,460 Added 35.54%
13,195 $46,000
Q2 2018

Aug 14, 2018
SELL
$2.15 - $3.6 $63,100 - $105,656
-29,349 Reduced 75.09%
9,735 $31,000
Q1 2018

May 11, 2018
BUY
$2.35 - $5.6 $76,107 - $181,361
32,386 Added 483.52%
39,084 $96,000
Q4 2017

Feb 09, 2018
BUY
$4.45 - $6.2 $29,806 - $41,527
6,698
6,698 $38,000

Others Institutions Holding AXSM

# of Institutions
403
Shares Held
37.4M
Call Options Held
507K
Put Options Held
540K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $5.09B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email